XML 26 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
Total
Series E Preferred Stock
Series F Preferred Stock
Total Stockholders’ Equity
Total Stockholders’ Equity
Series E Preferred Stock
Total Stockholders’ Equity
Series F Preferred Stock
Preferred Stock
Series E Preferred Stock
Preferred Stock
Series F Preferred Stock
Common Stock
Capital in Excess of Par Value
Capital in Excess of Par Value
Series E Preferred Stock
Capital in Excess of Par Value
Series F Preferred Stock
Accumulated Deficit
Accumulated Deficit
Series E Preferred Stock
Accumulated Deficit
Series F Preferred Stock
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Beginning balance at Dec. 31, 2018 $ 4,154,605,000     $ 4,154,250,000     $ 287,500,000 $ 345,000,000 $ 1,616,000 $ 3,950,055,000     $ (424,225,000)     $ (5,696,000) $ 355,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net earnings 299,608,000     299,180,000                 299,180,000       428,000
Dividends declared and paid:                                  
Preferred stock dividends declared and paid   $ (13,201,000) $ (17,940,000)   $ (13,201,000) $ (17,940,000)               $ (13,201,000) $ (17,940,000)    
Common stock dividends declared and paid (314,619,000)     (314,619,000)         4,000 19,069,000     (333,692,000)        
Redemption of depositary shares   $ (287,500,000)     $ (287,500,000)   (287,500,000)       $ (9,856,000)     $ (9,856,000)      
Issuance of common stock:                                  
Director compensation 1,294,000     1,294,000           1,294,000              
Stock purchase plan 370,000     370,000           370,000              
ATM equity program 127,337,000     127,337,000         24,000 127,313,000              
Equity offering 395,500,000     395,500,000         70,000 395,430,000              
Restricted shares - net of forfeitures and repurchases                 4,000 (4,000)              
Stock issuance costs (17,521,000)     (17,521,000)           (17,521,000)              
Amortization of deferred compensation 9,452,000     9,452,000           9,452,000              
Amortization of interest rate hedges 1,307,000     1,307,000                       1,307,000  
Fair value of forward starting swaps (5,524,000)     (5,524,000)                       (5,524,000)  
Valuation adjustments – available-for-sale securities 116,000     116,000                       116,000  
Realized gain – available-for-sale securities (1,331,000)     (1,331,000)                       (1,331,000)  
Other 505,000     505,000                 505,000        
Distributions to noncontrolling interests (776,000)                               (776,000)
Ending balance at Dec. 31, 2019 4,331,682,000     4,331,675,000     $ 0 345,000,000 1,718,000 4,495,314,000     (499,229,000)     (11,128,000) 7,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net earnings 228,796,000     228,799,000                 228,799,000       (3,000)
Dividends declared and paid:                                  
Preferred stock dividends declared and paid     (17,940,000)     (17,940,000)                 (17,940,000)    
Common stock dividends declared and paid (351,544,000)     (351,544,000)         1,000 4,864,000     (356,409,000)        
Issuance of common stock:                                  
Director compensation 1,132,000     1,132,000           1,132,000              
Stock purchase plan 308,000     308,000           308,000              
ATM equity program 121,315,000     121,315,000         31,000 121,284,000              
Restricted shares - net of forfeitures and repurchases                 3,000 (3,000)              
Stock issuance costs (2,212,000)     (2,212,000)           (2,212,000)              
Amortization of deferred compensation 13,084,000     13,084,000           13,084,000              
Amortization of interest rate hedges 2,300,000     2,300,000                       2,300,000  
Fair value of forward starting swaps (7,617,000)     (7,617,000)                       (7,617,000)  
Realized gain – available-for-sale securities 0                                
Ending balance at Dec. 31, 2020 4,319,304,000     4,319,300,000       345,000,000 1,753,000 4,633,771,000     (644,779,000)     (16,445,000) 4,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net earnings 290,110,000     290,113,000                 290,113,000       (3,000)
Dividends declared and paid:                                  
Preferred stock dividends declared and paid (14,999,000)     (14,999,000)                 14,999,000        
Common stock dividends declared and paid (364,792,000)     (364,792,000)           2,499,000     (367,291,000)        
Redemption of depositary shares     $ (345,000,000)     $ (345,000,000)   (345,000,000)       $ 10,897,000     $ (10,897,000)    
Issuance of common stock:                                  
Director compensation 1,145,000     1,145,000           1,145,000              
Stock purchase plan 320,000     320,000           320,000              
ATM equity program 1,234,000     1,234,000         1,000 1,233,000              
Restricted shares - net of forfeitures and repurchases                 3,000 (3,000)              
Stock issuance costs (299,000)     (299,000)           (299,000)              
Amortization of deferred compensation 13,151,000     13,151,000           13,151,000              
Amortization of interest rate hedges 3,073,000     3,073,000                       3,073,000  
Fair value of forward starting swaps (1,584,000)     (1,584,000)                       (1,584,000)  
Realized gain – available-for-sale securities 0                                
Ending balance at Dec. 31, 2021 $ 3,901,663,000     $ 3,901,662,000       $ 0 $ 1,757,000 $ 4,662,714,000     $ (747,853,000)     $ (14,956,000) $ 1,000